Jun Jiang1, Juan Yu1, Xiajing Liu1, Kan Deng2, Fan Lin1, and Liangping Luo3
1Shenzhen Second People's Hospital, Shenzhen, China, 2Philips Healthcare, Guangzhou, China, 3The First Affiliated Hospital of Jinan University, Guangzhou, China
Synopsis
Keywords: Tumors, MR Value
The purpose of this study is to
explore the efficacy of clinical and MRI-specific
features for tumor grading and the brain invasion assessment in patient with meningioma.
Our results showed that the tumor-brain interface is considered as a key factor, preoperative MRI
has excellent performance in diagnosing meningioma WHO grade and brain
invasion.
Introduction
Meningioma is one of the most
common brain tumors, accounting for 37.6% of primary intracranial tumors[1].WHO
grade 1 meningiomas have a very low recurrence rate after total resection.
However, with the increase of WHO grade of meningioma, the recurrence tendency
increased[2]. Besides, meningiomas with brain invasion exhibit
aggressive behaviors, an increased recurrence rate, and an increased risk of
postoperative seizures as well as postoperative bleeding[3-4]. Therefore, it is important to propose a non-invasion, efficient, and
reliable approach for the evaluation of tumor grade and brain invasion in meningioma. To our knowledge, the
imaging biomarkers of brain invasion are still unclear. Here, we aimed to
explore the efficacy of clinical and MRI-specific
features for tumor grading and the brain invasion assessment
in patient with meningioma.Materials and methods
675 patients with meningioma(108 with brain invasion) who underwent meningiomas
resected in our hospital from 2006 to 2022, were retrospectively enrolled in this study. MRI data including T1WI, T2WI, DWI and
contrast-enhanced T1WI (CE-T1WI) were acquired on a 3.0T MRI scanner (Ingenia; Philips Medical Systems, Best, The Netherlands). Two senior neuroradiologists who blinded to the pathological
findings analyzed the conventional MRI
characteristics according to the 2022 edition of the WHO
guidelines. For the ADC analysis, the slice with the
maximum tumor was selected and five ROIs were placed on the sloid portion of
the tumor. The average ADC value of five ROIs was calculated and a total of 17 features were acquired. Pathological findings,
which is the gold standard for the tumor grading and brain invasion assessment in meningioma, were reinterpreted by two
neuropathologists referring to the 2022 CNS WHO guideline. The
univariate logistic regression was performed to determine the independent risk
factors for meningioma WHO grading and brain invasion assessment. And then the significant
factors were further selected for multivariate logistic regression analysis. The
diagnostic efficacy was analyzed using the receiver operator characteristic
curve (ROC), and the area
under the curve (AUC), sensitivity and specificity were calculated. The
statistical analysis was performed with SPSS version 26.0 software, and a p value < 0.05
was considered statistically significant.Results
Univariate logistic regression analysis showed that sex, tumor size, lobulated
sign, peritumoral edema, vascular flow void, bone invasion, tumor-brain
interface, finger-like protrusion and mushroom sign were significant factors for meningioma
WHO grading, while sex, tumor size, lobulated sign,
peritumoral edema, ADC value, vascular flow void, bone invasion, tumor-brain
interface, finger-like protrusion and mushroom sign were significant factors for predicting
brain invasion. Multivariable logistic regression analysis showed that the
lobulated sign, tumor-brain interface, finger-like protrusion, mushroom sign
and bone invasion were independent risk factors for diagnosing meningioma WHO
Grades(Figure 1), while tumor size, ADC value, lobulated sign,
tumor-brain interface, finger-like protrusion, mushroom sign and bone invasion
were independent risk factors for diagnosing brain invasion (P < 0.05) (Figure 2-3). The tumor-brain interface had the highest
efficacy in evaluating WHO grade and brain invasion, with AUCs of
0.779 and 0.860, respectively(Figure 4). The fitting variables obtained by
multivariate logistic regression had AUCs of 0.834 and 0.935 for
determining WHO grade and brain invasion, respectively.Conclusions
Preoperative MRI has excellent performance in diagnosing meningioma WHO grade and brain
invasion, while the tumor-brain interface is considered as a key
factor. The preoperative MRI characteristics of meningioma can help predict WHO
grade and brain invasion, which may improve
the resection efficacy for the tumor and
invaded brain tissue, reduce
recurrence and mortality rates, as well as improve patient prognosis to some extent.Acknowledgements
No acknowledgement found.References
1. Euskirchen P, Peyre M. Management of
meningioma. Presse Med 2018; 47:e245-e252.
2. Huntoon K, Toland
A, Dahiya S. Meningioma: A Review of Clinicopathological and Molecular Aspects.
Front Oncol 2020; 10:579599.
3. Bulleid LS, James
Z, Lammie A, Hayhurst C, Leach PA. The effect of the revised WHO classification
on the incidence of grade II meningioma. Br J Neurosurg 2020; 34:584-586.
4. Hess K, Spille DC,
Adeli A, et al. Brain invasion and the risk of seizures in patients with
meningioma. J Neurosurg 2018; 130:789-796.